Staphylococcal infections--treatment and control.
D002353:Carrier State / Q000188:drug therapy; D002511:Cephalosporins / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control; D006760:Hospitalization; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D008248:Lysostaphin / Q000627:therapeutic use; D010019:Osteomyelitis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D013208:Staphylococcal Toxoid / Q000627:therapeutic use; D013209:Staphylococcal Vaccines / Q000627:therapeutic use; D013210:Staphylococcus; D013204:Staphylococcus Phages; D014640:Vancomycin / Q000627:therapeutic use; D014946:Wound Infection / Q000517:prevention & control
D002511:Cephalosporins; D010406:Penicillins; D013208:Staphylococcal Toxoid; D013209:Staphylococcal Vaccines; D014640:Vancomycin; D008248:Lysostaphin